American Bio Medica Co. (OTCMKTS:ABMC – Get Rating) passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.01 and traded as high as $0.02. American Bio Medica shares last traded at $0.01, with a volume of 577,420 shares changing hands.
American Bio Medica Price Performance
The company has a fifty day simple moving average of $0.01 and a 200-day simple moving average of $0.02.
American Bio Medica (OTCMKTS:ABMC – Get Rating) last posted its quarterly earnings results on Wednesday, November 16th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.21 million during the quarter.
American Bio Medica Company Profile
American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs.
- Get a free copy of the StockNews.com research report on American Bio Medica (ABMC)
- Bloom Energy Powers Up After an Upgrade, is it Worth the Risk?
- Why Hershey Is a Sweet Recession Stock
- Will Amazon Stock Be Delivering for Investors in 2023?
- The Analysts Shift Trucking Sentiment Back into Forward
- The Institutions Book A Flight With Boeing
Receive News & Ratings for American Bio Medica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Bio Medica and related companies with MarketBeat.com's FREE daily email newsletter.